Search Results

Gentuity’s Vis-M High-Frequency OCT Imaging System Directly Visualizes Neurovascular Pathologies in FIH Procedures

January 12, 2023—Gentuity, LLC, a Massachusetts-based imaging and artificial intelligence firm developing intravascular devices, announced the first-in-human (FIH) use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe.

Balt's Silk Vista Flow Diverter Approved in Europe

July 8, 2020—Balt announced it has received European CE Mark approval for its Silk Vista flow diverting stent to treat patients with unruptured intracranial aneurysms.

First Robotic-Assisted Aneurysm Coiling Performed With Corindus' CorPath GRX System

November 5, 2019—Corindus, a Siemens Healthineers company that develops precision vascular robotics, announced that its CorPath GRX system was used to complete the first-in-human robotic-assisted neurovascular intervention.

XCath Iris Surgical Robotic System Used in First Telerobotic Stroke Procedure

March 25, 2026—XCath, a developer of neuroendovascular surgical robotics, announced the completion of the first telerobotic stroke procedure with the XCath Iris surgical robotic system in a clinical investigation termed Operation Robo Angel.

Remedy N1 System Used in FIH Fully Remote Neurointerventional Procedures

October 8, 2025—Remedy Robotics, Inc., announced the first-in-human (FIH) procedures with its remotely operable endovascular robotic system, Remedy N1.

Sonorous NV’s BossStent to Treat Symptomatic Cerebral Venous Diseases Used in First Patients in North America

December 16, 2022—Sonorous NV, Inc. announced that the company’s BossStent device, which is designed to treat patients with symptomatic cerebral venous diseases, was used in the first patients in North America.

Viz.ai’s Cerebral Aneurysm Detection Module Receives FDA Clearance

February 24, 2022—Viz.ai announced it has received FDA 510(k) clearance for Viz Aneurysm, a new algorithm that uses artificial intelligence (AI) to detect suspected cerebral aneurysms.

Study Published of Biomodex Patient-Specific Brain Aneurysm Models for Preprocedural Rehearsals

July 1, 2020—Biomodex announced the results of the first clinical study of the Biomodex Evias three-dimensional (3D)–printed models to plan aneurysm treatment using endovascular robotics and novel flow diverter devices.

NeuroVasc’s Envi-SR Stent-Retriever Device Evaluated in Randomized Controlled Trial to Support Application for FDA Clearance

June 30, 2022—NeuroVasc Technologies, Inc. announced that the first patient has been treated in ENVI RCT, the NeuroVasc Envi-SR randomized controlled trial for endovascular treatment of ischemic stroke.

Study Suggests Cone-Beam CT Imaging Improves Time to Treatment for ELVO

July 27, 2021—The Society of NeuroInterventional Surgery (SNIS) announced findings from a study showing that using novel cone-beam CT (CB-CT) technology to improve image quality for stroke assessment may reduce the time to thrombectomy treatment for patients with emergent large vessel occlusion ischemic strokes.

Cone-Beam Imaging Shows Promise for Reducing Time to Stroke Care

July 24, 2018—The Society of NeuroInterventional Surgery (SNIS) announced the presentation of a study that suggests that in the future, stroke patients can bypass a CT scan or the emergency department and go directly to the angiosuite for imaging and proper care.

Reverse Medical ReFlex Catheter Cleared in US and Europe

April 26, 2011—Reverse Medical Corporation (Irvine, CA) announced that it has received US Food and Drug Administration 510(k) clearance to market the ReFlex line of intracranial catheters for distal neurovascular access and microcatheter therapeutic delivery.

Covidien Commences Enrollment for SWIFT PRIME Acute Ischemic Stroke Study

January 14, 2013—Covidien (Mansfield, MA) announced the launch of the SWIFT PRIME study, a multicenter, randomized controlled trial that will examine the adjunctive use of mechanical thrombectomy during the early stages of acute ischemic stroke onset.